Cancer Research · 2008 · 119 citations · 30 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular OncologyOncogenesApoptosis In CancerApoptosis RegulationApoptosis ResistanceCancer Cell SignalingOncogenic Signaling PathwaysTumor Suppressor GenesCell Growth RegulationCell Migration MechanismsCell Motility ModulationDominant Negative MutationsOncogene RegulationTumor Cell MotilityTumor Suppressor PathwaysYeast Two-hybrid Screening
Tripartite motif protein 32 (TRIM32) mRNA has been reported to be highly expressed in human head and neck squamous cell carcinoma, but the involvement of TRIM32 in carcinogenesis has not been fully elucidated. In this study, we found by using yeast two-hybrid screening that TRIM32 binds to Abl-interactor 2 (Abi2), which is known as a tumor suppressor and a cell migration inhibitor, and we showed that TRIM32 mediates the ubiquitination of Abi2. Overexpression of TRIM32 promoted degradation of Abi2, resulting in enhancement of cell growth, transforming activity, and cell motility, whereas a dominant-negative mutant of TRIM32 lacking the RING domain inhibited the degradation of Abi2. In addition, we found that TRIM32 suppresses apoptosis induced by cis-diamminedichloroplatinum (II) in HEp2 cell lines. These findings suggest that TRIM32 is a novel oncogene that promotes tumor growth, metastasis, and resistance to anticancer drugs.
30
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
The tripartite motif family identifies cell compartments
Alexandre Reymond, Germana Meroni, Anna Fantozzi et al. · The EMBO Journal · 2001 · 1.4K citations · Full text